珍宝岛：2025年全年预计净亏损101200万元—117300万元

Core Viewpoint - The company, Zhenbao Island, is forecasting a significant net loss for the year 2025, primarily due to adverse impacts from national pharmaceutical policy adjustments and other factors affecting sales performance [1] Financial Performance - The estimated net profit attributable to shareholders for 2025 is projected to be between -1,173 million and -1,012 million yuan, indicating a loss compared to the previous year [1] - The estimated net profit after deducting non-recurring gains and losses is expected to be between -1,234 million and -1,073 million yuan [1] Sales and Revenue Impact - The company's main products did not meet sales expectations, leading to a revenue decline of 53% year-on-year [1] - The average selling price of some products decreased, contributing to the overall revenue drop [1] Profitability and Losses - Gross profit decreased by 93% year-on-year due to the decline in sales [1] - The company faced credit impairment losses of approximately 394.68 million yuan due to delayed customer payments [1] - Asset impairment losses of about 266.48 million yuan were incurred due to a decrease in the realizable value of inventory [1]